TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Energy Stocks
TSX Today: What to Watch for in Stocks on Wednesday, December 7
Cannabis Stocks
5 Things to Know About Cannabis Stocks in November 2022
Investing
3 of the Best Growth Stocks to Buy Right Now
Cannabis Stocks
WEED Stock Skyrocketed 62% in 1 Week: Should You Invest?
Stocks for Beginners
TSX Today: What Could Increase Stock Market Volatility on Wednesday, October 26?
Investing
Why I’m Avoiding These TSX Sectors Right Now
Cannabis Stocks
If I’d Invested $100 in WEED Stock at the Start of 2022, Here’s What I’d Have Now
Cannabis Stocks
Biden’s Pot Pardon: Where Will Canopy Growth Be in 5 Years?
Cannabis Stocks
The Single Best Pot Stock to Buy in October
Investing
TSX Today: What to Watch for in Stocks on Wednesday, October 12
Tech Stocks
TSX Today: Why Canadian Stocks Could Fall on Tuesday, October 11